Skip to main content

Fall Sale - 40% Off Buy

Buy 0

A better way to treat depression

The Fisher Wallace Stimulator® is cleared by the FDA to treat depression. Proven in multiple clinical trials, the majority of patients experience results in two weeks. The device is also indicated by the FDA to treat anxiety and insomnia - the only medical device category of its kind. Take advantage of our special sale, and return it for a full refund if it’s not a game changer.

Profile view of a young black woman wearing a black and white turtleneck sweater in treatment with the Fisher Wallace stimulator. She has the headband on her head and electrodes in place above the side burns.

Advanced medical technology for rapid results

The brain is an electrical system. That's why a team of physicians and electrical engineers developed the Fisher Wallace Stimulator® to improve how the brain's neurons perform, as a viable alternative (and adjunct) to drug therapy.

Originally designed for hospital use, the device has been studied in seven clinical trials and is now used by over 85,000 patients at home.

The majority of our customers experience symptom reduction within the first two weeks, and 40% also report improvements in focus, concentration and memory. Use the device for 20 minutes at the start and end of each day for optimal results.

How it compares

Compared to drug therapy, ECT and TMS, the Fisher Wallace Stimulator® is the only treatment that is free of serious side effects, can be used at home, and offers a 30-day refund policy.

Fisher Wallace Drug Therapy ECT TMS
Indicated for Depression
Indicated for Anxiety
Indicated for Insomnia
Free of Serious Side Effects
Used at Home
30-Day Refund Policy

Evidence-based medicine

Fisher Wallace has invested millions of dollars in clinical research, including three large trials conducted during the pandemic and a pilot study at Mount Sinai Beth Israel Hospital (see graph) which found the Fisher Wallace Stimulator® to be successful in treating depression. Our most recent study launched In January 2022 - an anxiety and stress reduction program enrolling 200 uniformed police officers in the Seattle Police Department.

Research

Trusted by 14,000 doctors and 85,000 patients

More than 70% find relief - about twice the rate of antidepressants.

—  Richard Brown, MD at Columbia University

The device has improved my well being significantly over the best drug results I've had, and without the biochemical disruption caused by drugs (that means side effects).

—  Jeff S., Fisher Wallace Customer

In the news

"Columbia University Associate Clinical Professor of Psychiatry Richard P. Brown says he has used the device with 400 severely depressed patients and that more than 70% find relief, about twice the rate of anti-depressants."

"But since I couldn't stop talking about my good mood and hypercharged focus, my friends stopped laughing and started asking if they could borrow it. I'm reluctant to let go of my stimulator, however."

"The Fisher Wallace device...turned out to be the most impactful intervention in all my antidepressant exploration. At $499, it was an investment, but considering that most people with depression seek therapeutic treatments often not covered by health insurance, the possible savings on therapy and drugs over my lifetime seemed to justify the expense."

"5 Health-Tech Startups to Watch in 2021."

Back to top